PREVICOX DIN 02300168
Status: Marketed
Holder: BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
Health Canada record
| Active ingredient(s) | FIROCOXIB 57 MG |
|---|
| Dosage form | Tablet (Chewable) |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 06-Nov-2007 |
|---|
| Current status date | 10-Jun-2020 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FIROCOXIB
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02559501 | FIROKARE CHEWABLE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet (Chewable) | FIROCOXIB 57 MG | Marketed |
| 02559528 | FIROKARE CHEWABLE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet (Chewable) | FIROCOXIB 227 MG | Marketed |
| 02555174 | FIROLIX CHEWABLE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet (Chewable) | FIROCOXIB 57 MG | Approved |
| 02555182 | FIROLIX CHEWABLE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet (Chewable) | FIROCOXIB 227 MG | Approved |
| 02501228 | PREVEQUINE | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Tablet | FIROCOXIB 57 MG | Marketed |
| 02300176 | PREVICOX | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Tablet (Chewable) | FIROCOXIB 227 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 23755 | 2020-06-09 | New Drug Submission (NDS) | Administrative: Manufacturer Name Change |
| 10567 | 2009-09-01 | Supplement to a New Drug Submission (SNDS) | Addition of a claim: for the control of post-operative pain and inflammation associated with orthopedic surgery in dogs |
| 9721 | 2008-08-18 | Supplement to a New Drug Submission (SNDS) | ADDITIONAL CLAIM |
| 9061 | 2007-09-28 | New Drug Submission (NDS) | |
Request a quote for PREVICOX
How to read a Canadian DIN record